McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network

Core Insights - The article discusses the investment potential of MCK, highlighting a beneficial long position in its shares [1]. Company Analysis - MCK has shown promising performance, indicating a favorable outlook for investors [1]. - The analysis emphasizes the importance of understanding past performance as a factor in evaluating future investment opportunities [2]. Industry Context - The article does not provide specific details on the broader industry context or trends affecting MCK [2].